CGIM
BNTX icon

Capital Group Investment Management’s BioNTech BNTX Stock Holding History

Capital Group Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,697
Closed -$377K – 139
2024
Q2 		$377K Hold
4,697
– – 0.08% 133
2024
Q1 		$433K Buy
4,697
+420
+10% +$40.3K 0.08% 173
2023
Q4 		$451K Hold
4,277
– – 0.05% 180
2023
Q3 		$465K Hold
4,277
– – 0.03% 177
2023
Q2 		$462K Buy
4,277
+551
+15% +$62K 0.02% 182
2023
Q1 		$464K Sell
3,726
-615
-14% -$84.4K 0.02% 186
2022
Q4 		$652K Buy
+4,341
New +$668K 0.03% 179

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Group Investment Management's BNTX Position: Q3 2024 in Review

Capital Group Investment Management sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 4,697 shares — an estimated $377K sold.

Capital Group Investment Management first reported a position in BNTX in Q4 2022 and held it in 7 quarters. The position peaked at $652K in Q4 2022. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Capital Group Investment Management reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Capital Group Investment Management sold 4,697 BioNTech shares in Q3 2024, an estimated $377K.
  • Capital Group Investment Management first reported a position in BioNTech in Q4 2022 and held it in 7 quarters.
  • Capital Group Investment Management's BioNTech position peaked at $652K in Q4 2022.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Capital Group Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.